The Human Variable 

Why does IBD take months or years to diagnose? The failure is not missing symptoms. It is missing the pattern. CDF-IBD™ introduces a new framework for early detection of inflammatory bowel disease using pattern recognition, flare intelligence, and system-level correction. Designed to address IBS misdiagnosis, referral delays, and fragmented care, this model identifies IBD earlier, improves escalation, and reduces preventable disease progression.

POTS clinical trials often fail by treating a multi-system disorder as a narrow cardiovascular condition. This CYNAERA framework outlines stabilization, phenotype stratification, adaptive design, and real-world endpoints to improve outcomes and reduce trial failure.

Why rheumatoid arthritis is often misdiagnosed or delayed. Learn early RA symptoms, diagnostic gaps, and how CDF-RA™ improves early detection.

SymCas™ is a flare prediction model for POTS, Lyme disease, ME/CFS, Long COVID and relapsing chronic conditions. It identifies symptom patterns over time to detect early instability and support proactive care.

Personalized CRISPR Remission™ for ME/CFS explores customized, individualized gene-editing strategies based on immune state, environmental factors, and neuroimmune instability to enable state-dependent remission in infection-associated chronic conditions. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex, multi-system condition. Personalized CRISPR Remission™ for MECFS is not limited to one editing event or one delivery paradigm.

Personalized CRISPR Remission™ for sarcoidosis introduces a state-dependent precision medicine framework integrating immune biology, environmental exposure, safety modeling, and CYNAERA predictive systems to improve durable response and reduce variability.